Sign in

CIK 0001768224

  • Accelerated filer
  • Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-900-2660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Scientific Officer & COO sold 8,100 shares at $40.00 ($324,000)
  8. 4 Open-market sale Chief Scientific Officer & COO sold 3,633 shares at $40.00 ($145,328)
  9. 4 Open-market sale Chief Scientific Officer & COO sold 6,367 shares at $40.00 ($254,680)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $44.41 ($444,100)
  13. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $44.36 ($443,600)
  14. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $55.86 ($558,600)
  15. 4 Open-market sale Director sold 800,000 shares at an average $54.54 ($43,631,250)
  16. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $40.07 ($400,700)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 8 · 149 filings